Related Experiment Video
Updated: Jan 7, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
Functional genetic variants in immune-checkpoint molecules and susceptibility to Nasopharyngeal carcinoma in a
Wejden Gharbi1, Wicem Siala2, Olfa Abida3
1Autoimmunity, Cancer, and Immunogenetics Research Laboratory (LR18SP12), Immunology Department, Habib Bourguiba University Hospital, Sfax, Tunisia. gharbi.wejden1995@gmail.com.
Background:
Immune checkpoint pathways regulating T cell activity are key targets in cancer therapy. Genetic variations in checkpoint molecules (CTLA-4, PD-1, PD-L1) can alter signaling pathways, affecting cancer risk and treatment response in various types of malignancies.
Methods:
This study aimed to investigate associations between common polymorphisms in immune-regulating genes (CTLA-4, PDCD1 and CD274) and susceptibility to nasopharyngeal carcinoma (NPC) in the Tunisian population. We analyzed six polymorphisms: rs231775 and rs3087243 (CTLA-4), rs2227981, rs2227982, and rs36084323 (PDCD1), and rs2890658 (CD274) in a case-control study which enrolled 61 Tunisian NPC patients and 150 matched healthy controls using the PCR-RFLP method.
Results:
For the rs231775 SNP, our findings showed a significant association between the AA genotype and increased NPC susceptibility in the recessive model (GG + AG vs. AA) (pc=0.006, OR = 2.5, 95% CI: [1.35-4.6]). Further, the haplotype analysis showed that the rs231775 > A-rs3087243 > A-rs36084323 > G-rs2227982 > C-rs2227981 > C risk haplotype was significantly more expressed in NPC patients (p = 0.044, OR = 1.64, 95% CI: [1.02-2.63]). The phenotype-genotype association revealed that the rs231775 > AA genotype was significantly associated with clinical manifestations. We also confirmed that the rs2890658 > CC genotype was significantly associated with increased risk of NPC under the recessive model (AA + CA vs. CC), p = 0.0001, OR = 3.2, 95% CI: [1.71 - 5.96]. In addition, the rs2890658 > C variant had a 2.4-fold higher risk of NPC in comparison with the A allele (p = 0.0009, OR = 2.4, 95% CI: [1.42 - 4.08]).
Conclusion:
Our results suggest that the CTLA-4_rs231775 > AA and CD274_rs2890658 > CC genotypes could be considered as predisposition factors for NPC. These findings could pave the way for future investigations into NPC pathogenesis and assessing CTLA-4, PDCD1, and CD274 as personalized therapeutic targets.
Insights
Genetic variations in CTLA-4 (rs231775) and CD274 (rs2890658) are associated with increased nasopharyngeal carcinoma (NPC) risk in Tunisia. These findings highlight potential genetic predisposition factors for NPC.
Area of Science:
- Immunogenetics
- Cancer Epidemiology
- Molecular Biology
Background:
- Immune checkpoint pathways (CTLA-4, PD-1, PD-L1) are crucial in cancer therapy.
- Genetic variations in these pathways can influence cancer risk and treatment outcomes.
Purpose of the Study:
- To investigate the association between common immune gene polymorphisms and nasopharyngeal carcinoma (NPC) susceptibility in Tunisia.
- To identify specific genetic markers that may predispose individuals to NPC.
Main Methods:
- A case-control study involving 61 Tunisian NPC patients and 150 healthy controls.
- Analysis of six polymorphisms in CTLA-4, PDCD1, and CD274 genes using PCR-RFLP.
- Statistical analysis including genotype, haplotype, and phenotype-genotype associations.
Main Results:
- The CTLA-4 rs231775 AA genotype showed a significant association with increased NPC susceptibility (OR=2.5).
- A specific risk haplotype (rs231775-A, rs3087243-A, rs36084323-G, rs2227982-C, rs2227981-C) was more prevalent in NPC patients (OR=1.64).
- The CD274 rs2890658 CC genotype was strongly associated with increased NPC risk (OR=3.2), with the C allele conferring a 2.4-fold higher risk.
Conclusions:
- CTLA-4 rs231775 AA and CD274 rs2890658 CC genotypes may serve as predisposition factors for NPC.
- These genetic variations could inform future research on NPC pathogenesis.
- CTLA-4, PDCD1, and CD274 warrant further investigation as potential personalized therapeutic targets in NPC.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention
Some...

